JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 16, 2004; DOI: 10.1124/jpet.104.077644


0022-3565/05/3123-945-953$20.00
JPET 312:945-953, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.077644v1
312/3/945    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Virdis, A.
Right arrow Articles by Del Tacca, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Virdis, A.
Right arrow Articles by Del Tacca, M.

CARDIOVASCULAR

Cyclooxygenase-2 Inhibition Improves Vascular Endothelial Dysfunction in a Rat Model of Endotoxic Shock: Role of Inducible Nitric-Oxide Synthase and Oxidative Stress

Agostino Virdis, Rocchina Colucci, Matteo Fornai, Corrado Blandizzi, Emiliano Duranti, Stefania Pinto, Nunzia Bernardini, Cristina Segnani, Luca Antonioli, Stefano Taddei, Antonio Salvetti, and Mario Del Tacca

Department of Internal Medicine (A.V., E.D., S.P., S.T., A.S.), Division of Pharmacology and Chemotherapy, Department of Oncology, Transplants and Advanced Technologies in Medicine (R.C., M.F., C.B., L.A., M.D.T.), and Department of Human Morphology and Applied Biology, Section of Histology and General Embryology (N.B., C.S.), University of Pisa, Pisa, Italy

We investigated whether cyclooxygenase (COX) isoforms (COX-1 and COX-2) and decreased NO availability contribute to endothelial dysfunction in endotoxemic rats. The involvement of reactive oxygen species (ROS) was also evaluated. Rats were injected with Salmonella-derived lipopolysaccharide or saline. After 6 h, endothelial function of mesenteric resistance arteries was evaluated. In controls, acetylcholine (ACh)-induced relaxation was inhibited by the nitric-oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA) and unaffected by 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2(5H)-furanone (DFU) (COX-2 inhibitor). In lipopolysaccharide (LPS)-treated rats, the response to ACh was blunted compared with controls, less sensitive to L-NMMA, and enhanced by DFU. COX-2 blockade also improved the inhibitory effect of L-NMMA on cholinergic relaxation. SC-560 [5-(4-clorophenyl)-1-(4-metoxyphenyl)-3-trifluoromethylpirazole] (COX-1 inhibitor) did not modify the response to ACh in both groups. LPS-induced endothelial dysfunction was unaffected by the thromboxane A2 (TxA2) receptor antagonist SQ-29548 (7-[3-[[2-[(phenylamino)carbonyl]hydrazino]methyl]-7-oxabicyclo[2.2.1] hept-2-yl]-[1S(1alpha,2alpha(Z),3alpha,4alpha)]-5-heptenoic acid). In vivo inducible nitric-oxide synthase (iNOS) inhibition by S-methylisothiourea partly attenuated LPS-induced endothelial dysfunction. The antioxidants ascorbic acid and superoxide dismutase normalized endothelium-dependent relaxation and restored the inhibitory action of L-NMMA on ACh. Responses to sodium nitroprusside were similar in both groups. In LPS-treated rats, reverse transcription-polymerase chain reaction showed a marked increase in mesenteric iNOS and COX-2 expressions, whereas endothelial nitric-oxide synthase and COX-1 were unchanged. LPS-induced COX-2 overexpression was reduced but not abrogated by S-methylisothiourea. LPS-induced COX-2 up-regulation was also documented by immunohistochemistry. In conclusion, mesenteric resistance vessels from endotoxemic rats show impaired endothelial function due to reduced NO availability, a condition that is partly ascribable to an iNOS-dependent enhanced COX-2 expression, whereas TxA2 does not seem to be involved. Oxidative stress is the main mechanism responsible for reduced NO availability, and COX-2 might act as a source of ROS.


Received September 10, 2004; accepted November 15, 2004.

Address correspondence to: Dr. Agostino Virdis, Department of Internal Medicine, University of Pisa, Via Roma, 67, 56100 Pisa, Italy. E-mail: a_virdis{at}yahoo.com




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Foudi, L. Louedec, T. Cachina, C. Brink, and X. Norel
Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation
Cardiovasc Res, November 16, 2008; (2008) cvn287v2.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Hocherl, C. Schmidt, B. Kurt, and M. Bucher
Activation of the PGI2/IP System Contributes to the Development of Circulatory Failure in a Rat Model of Endotoxic Shock
Hypertension, August 1, 2008; 52(2): 330 - 335.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Hirao, K. Kondo, K. Takeuchi, N. Inui, K. Umemura, K. Ohashi, and H. Watanabe
Cyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteries
Cardiovasc Res, July 1, 2008; 79(1): 161 - 168.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Martinez-Revelles, F. Jimenez-Altayo, L. Caracuel, F. J. Perez-Asensio, A. M. Planas, and E. Vila
Endothelial Dysfunction in Rat Mesenteric Resistance Artery after Transient Middle Cerebral Artery Occlusion
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Antonioli, M. Fornai, R. Colucci, N. Ghisu, F. Da Settimo, G. Natale, O. Kastsiuchenka, E. Duranti, A. Virdis, C. Vassalle, et al.
Inhibition of Adenosine Deaminase Attenuates Inflammation in Experimental Colitis
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 435 - 442.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Virdis, R. Colucci, M. Fornai, E. Duranti, C. Giannarelli, N. Bernardini, C. Segnani, C. Ippolito, L. Antonioli, C. Blandizzi, et al.
Cyclooxygenase-1 Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries From Angiotensin II-Infused Mice
Hypertension, March 1, 2007; 49(3): 679 - 686.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. B. White
Cardiovascular Effects of the Cyclooxygenase Inhibitors
Hypertension, March 1, 2007; 49(3): 408 - 418.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Ghiadoni, E. Ferrannini, A. Salvetti, and F. Monzani
Low-Grade Systemic Inflammation Causes Endothelial Dysfunction in Patients with Hashimoto's Thyroiditis
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5076 - 5082.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Nieri, C. Martinelli, C. Blandizzi, N. Bernardini, R. Greco, C. Ippolito, M. Del Tacca, and M. C. Breschi
Role of Cyclooxygenase Isoforms and Nitric-Oxide Synthase in the Modulation of Tracheal Motor Responsiveness in Normal and Antigen-Sensitized Guinea Pigs
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 648 - 656.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-J. Gao, K. Takemori, L.-Y. Su, W.-S. An, C. Lu, A. M. Sharma, and R. M.K.W. Lee
Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion
Cardiovasc Res, July 15, 2006; 71(2): 363 - 373.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Jimenez-Altayo, A. M. Briones, J. Giraldo, A. M. Planas, M. Salaices, and E. Vila
Increased Superoxide Anion Production by Interleukin-1{beta} Impairs Nitric Oxide-Mediated Relaxation in Resistance Arteries
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 42 - 52.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Razmara, D. N. Krause, and S. P. Duckles
Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1843 - H1850.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Hermann, H. Krum, and F. Ruschitzka
To the Heart of the Matter: Coxibs, Smoking, and Cardiovascular Risk
Circulation, August 16, 2005; 112(7): 941 - 945.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.